Breast cancers are commonly categorized by their histopathological appearance (carcinoma in situ and invasive carcinoma) and molecularly by the expression of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor 2 (HER2) receptor. This evidence concerns the gene PGR and cancer.